Concepedia

Dennis Salonga

DS

Statistics

Publications

27

Citations

4K

H-Index

24

Active since

1997

Affiliations

University of Southern California(Current)

University of Cologne

USC Norris Comprehensive Cancer Center

Memorial Sloan Kettering Cancer Center

University of Maryland, Baltimore

Dennis Salonga is an author at University of Southern California specializing in medicine, molecular oncology, and oncology.

Publications per year

1997–2005

27

Publications

27

Colorectal tumors responding to 5-fluorouracil have low gene expression levels of dihydropyrimidine dehydrogenase, thymidylate synthase, and thymidine phosphorylase.

Dennis Salonga, Kathleen D. Danenberg, Martin R. Johnson et al. · PubMed · 2000 · 834 citations

Medicine, Molecular Biology, Oncology +16

ERCC1 mRNA levels complement thymidylate synthase mRNA levels in predicting response and survival for gastric cancer patients receiving combination cisplatin and fluorouracil chemotherapy.

R. Metzger, Cynthia G. Leichman, Kathleen D. Danenberg et al. · Journal of Clinical Oncology · 1998 · 510 citations

Medicine, Molecular Biology, Oncology +10

Epidermal growth factor receptor and HER2-neu mRNA expression in non-small cell lung cancer Is correlated with survival.

Jan Brabender, Kathleen D. Danenberg, Ralf Metzger et al. · PubMed · 2001 · 457 citations

Medicine, Oncology, Pathology +16

High basal level gene expression of thymidine phosphorylase (platelet-derived endothelial cell growth factor) in colorectal tumors is associated with nonresponse to 5-fluorouracil.

Ralf Metzger, Kathleen D. Danenberg, Cynthia G. Leichman et al. · PubMed · 1998 · 246 citations

Medicine, Oncology, Pharmacology +17

Telomerase reverse transcriptase expression is increased early in the Barrett's metaplasia, dysplasia, adenocarcinoma sequence

Reginald V. Lord, Dennis Salonga, Kathleen D. Danenberg et al. · Journal of Gastrointestinal Surgery · 2000 · 227 citations

Life Sciences, Molecular Biology, Pathology +11

1–5 of 27